Literature DB >> 3908544

Plasma lipoproteins and lipoprotein lipase in young diabetics with and without ketonuria.

P Rubba, B Capaldo, A Falanga, S Caprio, A Rivellese, G Riccardi, M Mancini.   

Abstract

Plasma lipoprotein and lipoprotein lipase activity have been evaluated in young diabetics with and without ketonuria and in healthy controls of the same age. Fifteen (age range 7-23 years) newly detected diabetics (8 with ketonuria, 7 non ketonuric) have been examined before starting the treatment. Five healthy medical students (age range 19-21 years) have also been studied. Both ketotic and non ketotic patients showed an impaired insulin and C-peptide response to the glucose load in comparison to controls. Ketotic patients had low lipoprotein lipase activity (p less than 0.01) and high density lipoprotein (p less than 0.01); total plasma Triglycerides and VLDL Triglyceride and Cholesterol were higher than in controls. Plasma Triglyceride and VLDL Triglyceride and Cholesterol were inversely related to lipoprotein lipase activity. Low lipoprotein lipase activity, from adipose tissue and muscle, has been found to be associated with hypertriglyceridemia and reduced HDL Cholesterol in young diabetic patients with ketonuria.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3908544     DOI: 10.1007/BF03348532

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes).

Authors:  J D Brunzell; D Porte; E L Bierman
Journal:  Metabolism       Date:  1975-10       Impact factor: 8.694

2.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

3.  Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Relation to high-density and very-low-density lipoproteins and response to treatment.

Authors:  M R Taskinen; E A Nikkilä
Journal:  Diabetologia       Date:  1979-12       Impact factor: 10.122

Review 4.  Enzymatic determination of hexoses in blood and urine.

Authors:  M Hjelm
Journal:  Scand J Clin Lab Invest Suppl       Date:  1966

5.  Lipolytic activities in post-heparin plasma in man measured with different substrate emulsions.

Authors:  B Vessby; J Boberg; H Lithell
Journal:  Clin Sci Mol Med       Date:  1978-02

Review 6.  Lipolytic enzymes and plasma lipoprotein metabolism.

Authors:  P Nilsson-Ehle; A S Garfinkel; M C Schotz
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

7.  Plasma lipoproteins in maturity onset diabetes.

Authors:  M Mancini; A Rivellese; P Rubba; G Riccardi
Journal:  Nutr Metab       Date:  1980       Impact factor: 4.169

8.  Effects of clofibrate treatment on plasma triglyceride concentration, plasma post-heparin clearing factor lipase (lipoprotein lipase) activity and serum clearing factor lipase activating ability in maturity-onset diabetes.

Authors:  M P Rogers; D Barnett; D S Robinson
Journal:  Atherosclerosis       Date:  1976-09       Impact factor: 5.162

9.  Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity.

Authors:  O J Pykälistö; P H Smith; J D Brunzell
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

10.  Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.

Authors:  E A Nikkilä; J K Huttunen; C Ehnholm
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

View more
  4 in total

1.  Perturbations in the lipid profile of individuals with newly diagnosed type 1 diabetes mellitus: lipidomics analysis of a Diabetes Antibody Standardization Program sample subset.

Authors:  Christina M Sorensen; Jie Ding; Qibin Zhang; Thierry Alquier; Rui Zhao; Patricia W Mueller; Richard D Smith; Thomas O Metz
Journal:  Clin Biochem       Date:  2010-05-16       Impact factor: 3.281

2.  Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation.

Authors:  A Rivellese; G Riccardi; G Romano; R Giacco; L Patti; G Marotta; G Annuzzi; M Mancini
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

3.  Adrenergic blocking agents and lipoprotein lipase activity.

Authors:  P Rubba; B De Simone; T Marotta; G Leccia; S Soro; L A Ferrara
Journal:  J Endocrinol Invest       Date:  1989-02       Impact factor: 4.256

4.  Mixture of Organophosphates Chronic Exposure and Pancreatic Dysregulations in Two Different Population Samples.

Authors:  Mbah Ntepe Leonel Javeres; Saqlain Raza; Ngondi Judith; Fozia Anwar; Rabia Habib; Sajida Batool; Syed Muhammed Nurulain
Journal:  Front Public Health       Date:  2020-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.